- Previous Close
374,000.00 - Open
372,000.00 - Bid 387,000.00 x --
- Ask 387,500.00 x --
- Day's Range
369,500.00 - 391,500.00 - 52 Week Range
258,000.00 - 391,500.00 - Volume
77,574 - Avg. Volume
51,024 - Market Cap (intraday)
5.614T - Beta (5Y Monthly) 0.56
- PE Ratio (TTM)
-- - EPS (TTM)
-- - Earnings Date Aug 5, 2024 - Aug 9, 2024
- Forward Dividend & Yield 5,500.00 (1.47%)
- Ex-Dividend Date Mar 28, 2024
- 1y Target Est
450,636.00
CJ Cheiljedang Corporation engages food and bio businesses in South Korea and internationally. The company offers home meal replacement, meat/fishery processing, seasoning/sauce, health food/ginseng beverage, sweetener/flour/oil, and seaweed/dessert/snack products. It also provides amino acid, green protein, enzyme, plant nutrition and health, and specialty solution; biomaterials, such as resins, compounds, and masterbatches; and microbiomes drug development for genetic based infection disease. In addition, the company taste and beyond products; nutrition solutions; and alternative and cultured proteins. Further, the company engages in the feed, livestock, and fresh meat business. It serves under the bibigo, Hetbahn, Gourmet, Beksul, The Healthy, DASIDA, Haechandle, SPAM, Samho Eomuk, Hasunjung, Happy Soy, Dadam, SANDRAE, METIER, BYO, Returnup, Petitzel, Maxbon, Matbam, Hanppuri, Joy of Growing Together, TasteNrich, FlavorNrich, AMINATURE, Bestamino, PHACT, Soytide, Xsoy, Immprober, and Biotector brand names. CJ Cheiljedang Corporation was founded in 1953 and is based in Seoul, South Korea.
www.cj.co.kr--
Full Time Employees
December 31
Fiscal Year Ends
Sector
Industry
Recent News: 097950.KS
Performance Overview: 097950.KS
Trailing total returns as of 6/14/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: 097950.KS
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: 097950.KS
Valuation Measures
Market Cap
5.99T
Enterprise Value
15.51T
Trailing P/E
12.72
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
0.21
Price/Book (mrq)
0.81
Enterprise Value/Revenue
0.53
Enterprise Value/EBITDA
5.31
Financial Highlights
Profitability and Income Statement
Profit Margin
1.62%
Return on Assets (ttm)
2.91%
Return on Equity (ttm)
5.64%
Revenue (ttm)
29.17T
Net Income Avi to Common (ttm)
439.22B
Diluted EPS (ttm)
--
Balance Sheet and Cash Flow
Total Cash (mrq)
2.52T
Total Debt/Equity (mrq)
101.96%
Levered Free Cash Flow (ttm)
1.99T